Sayson, Amarah Zia A.

HRN: 21-39-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2025
CEFUROXIME 750MG (VIAL)
05/09/2025
05/16/2025
INTRAVENOUS
310 Mg
Every 12 Hours
Acute Bacterial Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: